USANA HEALTH SCIENCES, INC. Net Income (Loss) Attributable to Redeemable Noncontrolling Interest
USANA HEALTH SCIENCES, INC. (USNA) reported Net Income (Loss) Attributable to Redeemable Noncontrolling Interest of -$6.57 million for the 3-month period ending 2026-07-04, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToRedeemableNoncontrollingInterest · last filed 2026-08-13
- USANA HEALTH SCIENCES, INC. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2026-07-04 was -$6.57M, a 932.57% decline year-over-year.
- USANA HEALTH SCIENCES, INC. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2026-04-04 was -$556.00K.
- USANA HEALTH SCIENCES, INC. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2026-01-03 was $180.00K, a 500.00% increase year-over-year.
- USANA HEALTH SCIENCES, INC. net income (loss) attributable to redeemable noncontrolling interest for the quarter ending 2025-09-27 was -$140.00K.
- USANA HEALTH SCIENCES, INC. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2026 was $717.00K, a 2290.00% increase from fiscal 2024.
- USANA HEALTH SCIENCES, INC. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2024 was $30.00K.
- USANA HEALTH SCIENCES, INC. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2023 was $0.00.
- USANA HEALTH SCIENCES, INC. net income (loss) attributable to redeemable noncontrolling interest for fiscal 2022 was $0.00.
| Period end | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Redeemable Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-07-04 | -$6.57M 10-Q · filed 2026-08-13 | -$7.13M 10-Q · filed 2026-08-13 | -$6.95M derived: sum of 3 quarters · filed 2026-08-13 | -$7.08M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-04-04 | -$556.00K 10-Q · filed 2026-05-12 | -$376.00K derived: sum of 2 quarters · filed 2026-05-12 | -$516.00K derived: sum of 3 quarters · filed 2026-05-12 | $273.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-01-03 | $180.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $40.00K derived: sum of 2 quarters · filed 2026-03-16 | $829.00K derived: sum of 3 quarters · filed 2026-08-13 | $717.00K 10-K · filed 2026-03-16 |
| 2025-09-27 | -$140.00K 10-Q · filed 2025-11-05 | $649.00K derived: sum of 2 quarters · filed 2026-08-13 | $537.00K 10-Q · filed 2025-11-05 | $567.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-28 | $789.00K 10-Q · filed 2026-08-13 | $677.00K 10-Q · filed 2026-08-13 | $707.00K derived: sum of 3 quarters · filed 2026-08-13 | $707.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-29 | -$112.00K 10-Q · filed 2026-05-12 | -$82.00K derived: sum of 2 quarters · filed 2026-05-12 | -$82.00K derived: sum of 3 quarters · filed 2026-05-12 | -$82.00K derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-28 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $30.00K derived: sum of 2 quarters · filed 2026-03-16 | $30.00K derived: sum of 3 quarters · filed 2026-03-16 | $30.00K 10-K · filed 2026-03-16 |
| 2024-09-28 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | |
| 2024-06-29 | $0.00 10-Q · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | ||
| 2024-03-30 | $0.00 10-Q · filed 2025-05-06 | |||
| 2023-12-30 | $0.00 10-K · filed 2026-03-16 | |||
| 2022-12-31 | $0.00 10-K · filed 2025-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |